American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

10.3322/canjclin.52.6.342

10.1097/LGT.0b013e3181585870

10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#

10.1023/A:1018435522475

Parkin, 2006, Chapter 2: The burden of HPV-related cancers, Vaccine, 24, S3/11

10.3322/caac.20138

American Cancer Society . Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012.

10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

10.1016/S1470-2045(10)70230-8

10.1056/NEJMoa021641

10.1056/NEJMp020178

10.1016/S0140-6736(07)61416-0

Mosher WD Chandra A Jones J . Sexual behavior and selected health measures: men and women 15–44 years of age, United States, 2002. Adv Data. 2005:1–55.

10.1086/516784

10.1093/jnci/djn044

10.1136/bmj.b2569

10.1093/jnci/djq356

10.1016/S1470-2045(08)70103-7

10.1097/AOG.0b013e3181e3e719

10.1016/S0002-9378(03)00418-6

10.1093/jnci/95.1.46

10.1136/bmj.a1754

10.1158/1055-9965.EPI-11-0206

Freeman H Wingrove B . Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute; 2005.

Division of Cancer Prevention and Control, National Center for Disease Prevention and Health Promotion, Centers for Disease Control and Prevention . Cervical Cancer. Atlanta, GA: 2011. http://www.cdc.gov/cancer/cervical/. Accessed October 21, 2011.

10.1016/j.ypmed.2007.06.007

10.1002/cncr.25065

10.1309/PT3PNC1QL2F4D2VL

10.1097/AOG.0b013e31818f5008

10.1158/1078-0432.CCR-04-2599

10.1136/bmj.a1284

10.1016/j.amjmed.2004.08.021

10.1097/LGT.0b013e3181cec411

10.1097/AOG.0b013e3181c6f8a4

10.1097/01.AOG.0000296488.85807.b3

10.1001/jama.2009.1569

10.1002/ijc.21955

10.1056/NEJMoa071430

10.1056/NEJMoa073204

10.1016/S0140-6736(07)61450-0

10.1016/S1470-2045(09)70360-2

10.1136/bmj.c1804

10.1016/S1470-2045(11)70188-7

10.1177/002215540104900918

10.1309/BA43HMCAJ26VWQH3

10.1309/84E5WHJQHK83BGQD

10.1002/ijc.24010

10.1309/RNF3C01JKADQCLKP

10.1309/AJCPRI8XPQUEAA3K

10.1016/j.jcv.2004.12.011

10.1136/bmj.39493.646875.AE

10.1136/bmj.39504.506319.80

10.1136/bmj.39490.551019.BE

10.1136/bmj.39489.470347.AD

10.1136/bmj.a744

10.1136/bmj.39500.677199.AE

Kaplan, 2009, Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, MMWR Recomm Rep, 58, 1

10.1097/LGT.0b013e3181d95ad6

10.1136/bmj.b2968

10.3322/canjclin.57.1.7

Markowitz, 2007, Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 56, 1

10.1001/archinte.168.17.1881

Kulasingam S Havrilesky L Ghebre R Screening for Cervical Cancer: A Decision Analysis for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2011. AHRQ Pub. No. 11-05157-EF-1.

10.1038/bjc.1996.196

10.1038/sj.bjc.6600974

10.1001/jama.297.8.813

10.1086/320696

10.1038/sj.bjc.6602002

10.1097/01.AOG.0000120143.50098.c7

10.1093/jnci/dji162

10.1016/S0029-7844(02)02454-7

10.1080/j.1600-0412.1998.770219.x

10.1056/NEJMoa035419

10.1016/S1470-2045(11)70145-0

Australian Institute of Health and Welfare . Cervical Screening in Australia 2008–2009. Canberra, Australian Capital Territory, Australia: Australian Institute of Health and Welfare; 2011.

10.1158/1055-9965.EPI-05-0231

10.1002/cncr.20064

10.1097/01.AOG.0000109426.82624.f8

10.1001/archinternmed.2010.134

Arbyn, 2006, Chapter 9: clinical applications of HPV testing: a summary of meta-analyses, Vaccine, 24, S3/78

10.1001/jama.285.11.1500

10.1016/S1470-2045(09)70156-1

10.1016/S1470-2045(09)70246-3

Vijayaraghavan, 2010, Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Quebec, Canada, Can J Public Health, 101, 220, 10.1007/BF03404377

10.1016/j.ygyno.2006.08.053

10.1038/bjc.1995.172

Zappa, 2004, Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence, Br J Cancer, 90, 1784, 10.1038/sj.bjc.6601754

10.1002/ijc.22357

10.1093/jnci/djj067

10.1016/S0002-9378(03)00413-7

10.1002/ijc.24752

10.1093/jnci/dji187

10.1309/AJCPTUS5EXAS6DKZ

10.1093/jnci/djr283

10.1093/jnci/djn510

10.1002/ijc.25396

10.1038/sj.bjc.6690523

10.1016/S0140-6736(03)14955-0

10.1309/AJCPAZV88VIFZSFD

10.1158/0008-5472.CAN-06-1057

10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z

Peto, 2004, Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort, Br J Cancer, 91, 942, 10.1038/sj.bjc.6602049

10.1309/AJCPZ5JY6FCVNMOT

10.1097/01.AOG.0000263461.71732.40

10.1093/jnci/dji186

10.1097/AOG.0b013e3181996ffa

10.7326/0003-4819-148-7-200804010-00004

10.1016/S1470-2045(08)70208-0

10.1093/jnci/djp367

10.1016/j.ejca.2011.01.008

Vesco K Whitlock E Eder M Screening for Cervical Cancer: A Systematic Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 86. Rockville, MD: Agency for Healthcare Research and Quality; 2011. AHRQ Pub. No. 11-05156-EF-1.

10.1371/journal.pone.0012724

10.1002/cncr.23747

10.1001/jama.1986.03380030069030

10.1016/S0029-7844(00)00882-6

10.1093/jnci/dji115

10.1093/jnci/djp089

10.1002/ijc.21604

10.1093/jnci/djq001

10.1002/cncr.23757

10.1056/NEJM199611213352103

10.1016/0002-9378(95)90262-7

10.3122/15572625-13-4-233

10.1016/S0002-9378(99)70601-0

10.1111/j.1471-0528.1992.tb14440.x

2011, National and state vaccination coverage among adolescents aged 13 through 17 years–United States, 2010, MMWR. Morb Mortal Wkly Rep, 60, 1117

10.1056/NEJMoa061741

10.1086/522864

10.1016/S0140-6736(07)60852-6

10.1086/597307

10.1093/jnci/djp534

10.1016/S0140-6736(09)61248-4

10.1016/S0140-6736(09)61567-1

10.1093/eurpub/ckn064

10.1016/j.vaccine.2007.04.086

10.1038/sj.bjc.6605528

10.1016/j.vaccine.2011.07.096

10.3201/eid1301.060438

10.1159/000214924

10.1080/00016340802566770

10.1093/jnci/djh104

10.1001/jama.290.6.781

10.1038/sj.bjc.6604162

10.1016/j.ejca.2010.06.016

10.1071/SH07043

10.1016/j.vaccine.2007.09.035

10.1017/S0266462309090217

10.1093/jnci/djn019

Franco, 2006, Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination, Vaccine, 24, S3/171

10.1016/j.arcmed.2009.06.003

10.1002/ijc.24000

New Mexico Human Papillomavirus (HPV) Pap Registry (NMHPVPR) and HOPE Clinic (House of Prevention Epidemiology) . http://www.unm.edu/~nmhpvpr/. Accessed January 15, 2012.

10.1007/s10552-011-9877-6

Public Health Agency of Canada . Performance Monitoring for Cervical Cancer Screening Programs in Canada: Report From the Screening Performance Indicators Working Group, Cervical Cancer Prevention and Control Network. Ottawa, Ontario, Canada; 2009.

10.1002/ijc.26202

10.1016/j.ypmed.2011.03.018

10.1001/jama.2011.1800

10.1016/S1470-2045(11)70296-0